Funding for this research was provided by:
Bill and Melinda Gates Foundation (1106078)
Received: 2 September 2020
Accepted: 2 March 2021
First Online: 10 March 2021
: The overall study protocol received clearance from the National Health Sciences Research Committee (NHSRC) of the Ministry of Health in Malawi (approval number: NHSRC # 16/3/1559). Secondary data were used for the cost-effectiveness modelling.
: Not applicable.
: PGI, JBL, MAM, PC and BDG work for AMP which receives unrestricted funding from Sanofi Pasteur and grant-specific support from Crucell, Sanofi Pasteur, Pfizer, Merck, and GlaxoSmithKline.